TYK2 drugs for Systemic Lupus Erythematosus

4 tracked TYK2 drugs in the Systemic Lupus Erythematosus race. The class explanation lives on the TYK2 page; the full indication pipeline across every mechanism is on the Systemic Lupus Erythematosus page.

1 Phase 33 Phase 2

Head-to-head evidence: Envudeucitinib vs Nomelcitinib (D-2570) · Envudeucitinib vs TQH3906 · deucravacitinib vs Envudeucitinib

The roster

← all TYK2 drugs